A comparison of clinical, utilization, and cost outcomes between oral treatments for multiple sclerosis

By: Patrick Rasca, MS, Claire Kiss, PharmD, BCPS, Lauren Stevens, MPH, MS, RD, and Jeffrey J. Ellis, PharmD, MS

Multiple sclerosis (MS) affects nearly 1 million people in the United States and causes significant disability and economic loss. Among the first available oral MS treatment options, clinical outcome comparisons and associated health care resource utilization are not clearly defined.

Read article: JMCP.org